Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Works matching IS 13518216 AND DT 2007 AND VI 13 AND IP 6
Results: 18
1
2
Factor VIII inhibitor associated with nephrotic syndrome.
- Published in:
- 2007
- By:
- Publication type:
- Letter
3
Analysing two dinucleotide repeats of FVIII gene in Iranian population.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 740, doi. 10.1111/j.1365-2516.2007.01471.x
- By:
- Publication type:
- Article
4
Galectin 3-binding protein is a potential contaminant of recombinantly produced factor IX.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 701, doi. 10.1111/j.1365-2516.2007.01525.x
- By:
- Publication type:
- Article
5
Successful liver transplant in an HCV-infected haemophiliac patient with fulminant hepatic failure.
- Published in:
- 2007
- By:
- Publication type:
- Letter
6
Experience with epidural anaesthesia in pregnant women with von Willebrand disease.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 730, doi. 10.1111/j.1365-2516.2007.01547.x
- By:
- Publication type:
- Article
7
Management of an acute coronary syndrome in a patient with severe haemophilia A.
- Published in:
- 2007
- By:
- Publication type:
- Letter
8
Multiple congenital coagulopathies co-expressed with Von Willebrand’s disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 685, doi. 10.1111/j.1365-2516.2007.01541.x
- By:
- Publication type:
- Article
9
The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUM.
- Published in:
- 2007
- By:
- Publication type:
- Report
10
Inhibitor development and successful immune tolerance in an HIV-infected patient with haemophilia A and after immune reconstitution with HAART.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 707, doi. 10.1111/j.1365-2516.2007.01543.x
- By:
- Publication type:
- Article
11
Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 734, doi. 10.1111/j.1365-2516.2007.01544.x
- By:
- Publication type:
- Article
12
Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 712, doi. 10.1111/j.1365-2516.2007.01531.x
- By:
- Publication type:
- Article
13
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 722, doi. 10.1111/j.1365-2516.2007.01548.x
- By:
- Publication type:
- Article
14
Prenatal diagnosis of haemophilia A by using intron 1 inversion detection.
- Published in:
- 2007
- By:
- Publication type:
- Letter
15
Haemoperitoneum in a female patient with haemophilia A caused by a ruptured ovarian follicle.
- Published in:
- 2007
- By:
- Publication type:
- Letter
16
Safety and efficacy of a plasma-derived monoclonal purified factor VIII concentrate during 10 years of follow-up.
- Published in:
- Haemophilia, 2007, v. 13, n. 6, p. 697, doi. 10.1111/j.1365-2516.2007.01554.x
- By:
- Publication type:
- Article
17
Venous thrombosis in Glanzmann’s thrombasthenia.
- Published in:
- 2007
- By:
- Publication type:
- Letter
18
Coagulation deficiencies: a look to the future.
- Published in:
- 2007
- By:
- Publication type:
- Report